Chamber, Drugmakers Back AbbVie In $448M FTC Fine Appeal

By Matthew Santoni (June 13, 2019, 9:08 PM EDT) -- Drugmakers and the U.S. Chamber of Commerce urged the Third Circuit on Wednesday to overturn a ruling that slammed AndroGel maker AbbVie with $448 million in penalties for bringing "sham" patent suits to slow down generic competitors, arguing that the Pennsylvania federal judge on the case made it harder to file legitimate patent defenses....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!